Bio-Techne Q2 adjusted EPS rises to $0.46 as revenue holds flat at $295.9 million
Bio-Techne reported fiscal second-quarter results for the three months ended December 31, 2025, with revenue flat at $295.9 million and GAAP operating income up 15% to $54.5 million. Adjusted EPS rose to $0.46 from $0.42, and the company also declared an $0.08 per share quarterly dividend.
Key points
- Revenue was $295.9 million, flat versus the prior year, with foreign currency adding 2% and a held-for-sale business reducing revenue by 2%.
- GAAP EPS was $0.24 versus $0.22; adjusted EPS was $0.46 versus $0.42.
- Adjusted operating margin was 31.1% versus 30.1%, and GAAP operating income rose to $54.5 million from $47.4 million.
- The $0.08 per share dividend is payable February 27, 2026, to shareholders of record on February 16, 2026.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 12:56 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 04, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.